Form 4: Atlassian Co-CEO Scott Farquhar Sells Class A Common Stock
SEC Form 4
Atlassian's Co-CEO, Scott Farquhar, executed multiple sales of Class A Common Stock on July 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Scott Farquhar, Co-CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on July 22, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on February 14, 2024.
- The transactions involved multiple trades at varying prices, with weighted-average prices reported for each set of trades.
- A total of 7,948 shares were sold at prices ranging from $174.49 to $178.04.
- Following the reported transactions, Farquhar indirectly owns 389,452 to 395,564 shares through the Farquhar Family Trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 plan suggests the sales were scheduled in advance.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The sales do not appear to have any direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/14/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 07/22/2024 | Date of stock sale transactions |
| 07/23/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.